Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2019-12-03 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
第三届董事会第二十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of 普莱柯生物工程股份有限公司. It details the meeting date, attendance, and specific agenda items approved by the board, including investment in a new building and a proposal for a shareholder meeting. There is no financial data, earnings information, or detailed report content. The document is not a full annual or interim report, nor is it a call transcript or audit report. It is not a voting result announcement from a shareholder meeting but rather a board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short and focused on board decisions, confirming this classification with high confidence.
2019-12-03 Chinese
关于收购南京梅里亚股权完成工商变更登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 普莱柯生物工程股份有限公司 regarding the completion of the acquisition of 100% equity in 南京梅里亚动物保健有限公司 and the subsequent change in business registration. It details the registration information of the newly acquired company, including legal representative, registered capital, and business scope. There is no financial data, no mention of a report or filing of financial results, nor is it a meeting material or voting result. The content is about a corporate acquisition and registration update, which fits best under Capital/Financing Update (CAP) as it relates to company fundraising or capital structure changes through acquisition.
2019-11-21 Chinese
股东减持股份进展公告
Major Shareholding Notification Classification · 100% confidence The document is a shareholder announcement regarding the progress of a major shareholder's reduction in shareholding. It details the number of shares held before and after the reduction, the method of reduction, and the impact on company control. It does not contain financial statements or performance data, nor is it a report or presentation. It is a notification about a change in major shareholding levels, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming this classification.
2019-11-14 Chinese
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding the receipt of a new veterinary drug registration certificate. It details the approval process, product information, and significance to the company. The document is short (1316 characters) and serves as a formal notification of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management changes. It is not a report publication announcement since it is the announcement itself. The content fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about a new product approval.
2019-11-12 Chinese
第三届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司. It details the convening of the board meeting, attendance, and the voting results on specific investment decisions. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory certifications. The content focuses on board decisions and approvals, specifically regarding investment in equity shares. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2019-10-31 Chinese
关于取得南京梅里亚股权的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 普莱柯生物工程股份有限公司 regarding the acquisition of 50% equity in 南京梅里亚动物保健有限公司, detailing the transaction overview, parties involved, financial information of the target company, and risk analysis. It includes specifics about the transaction price, dates, and regulatory filings related to the equity transfer. The document is not a financial report, earnings release, or management discussion but rather a formal disclosure of a capital investment transaction. It does not contain comprehensive financial statements or quarterly/yearly financial performance data. The document length is 3674 characters, which is relatively short and focused on the transaction announcement. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as equity acquisitions.
2019-10-31 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.